{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-016984","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.075900+00:00","generated_at":"2026-06-14T05:22:57.389968+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vaxart prices $15M public offering of 16M shares; net ~$13.6M","bullets":["Offering of 16M shares of common stock at $0.9375 per share for gross proceeds of $15M.","Net proceeds expected ~$13.6M (or ~$15.7M if underwriter's 30-day option fully exercised).","Underwriter Cantor Fitzgerald granted a 30-day option to purchase up to 2.4M additional shares.","Proceeds to be used for clinical/preclinical development, manufacturing, and general corporate purposes.","Offering expected to close June 9, 2023, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-016984","json":"https://secwatch.observer/filing/0001437749-23-016984.json","markdown":"https://secwatch.observer/filing/0001437749-23-016984.md","text":"https://secwatch.observer/filing/0001437749-23-016984.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774923016984/0001437749-23-016984-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774923016984/vxrt20230608_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:22:57.389968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c60b9c3dbd6c26f355c28799bde5085a30a3f8fd","claim":"Vaxart, Inc. entered into Underwriting Agreement with Cantor Fitzgerald & Co. (effective 2023-06-07).","evidence_excerpt":"On June 7, 2023, Vaxart, Inc. (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) to issue and sell to Cantor 16,000,000 shares of the Company’s common stock, par value $0.0001 (the “Common Shares”) in an underwritten public offering (the “Offering”), pursuant to a Registration Statement on Form S-3 (File No. 333-270671) and the related prospectus and prospectus supplement, in each case filed with the U.S. Securities and Exchange Commission (the “SEC”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923016984/0001437749-23-016984-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Cantor Fitzgerald & Co."},{"label":"Effective","value":"2023-06-07"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}